BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 13971658)

  • 1. The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy. A new method for determination of preformed clot lysis.
    BLIX S
    Acta Med Scand Suppl; 1962; 386():1-24. PubMed ID: 13971658
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of clot lysis by streptokinase and effects of epsilon-aminocaproic acid.
    ABLONDI FB; DE RENZO EC
    Proc Soc Exp Biol Med; 1959; 102():717-9. PubMed ID: 13791495
    [No Abstract]   [Full Text] [Related]  

  • 3. THE EFFECT OF COPPER IONS ON CLOT LYSIS TIME IN THE FIBRINOLYTIC ASSAY OF STREPTOKINASE.
    BOGERT AB
    Thromb Diath Haemorrh; 1965 Jun; 13():477-83. PubMed ID: 14347869
    [No Abstract]   [Full Text] [Related]  

  • 4. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW.
    LIEBERMAN J
    Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THROMBOANGIITIS OBLITERANS: WITH SPECIAL REFERENCE TO COAGULATION AND CLOT LYSIS.
    ENDE N
    Vasc Dis; 1964 Mar; 1():83-8. PubMed ID: 14186546
    [No Abstract]   [Full Text] [Related]  

  • 6. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lysis of human blood clots in vitro].
    ROSOLLECK H
    Klin Wochenschr; 1961 Apr; 39():440-4. PubMed ID: 13743567
    [No Abstract]   [Full Text] [Related]  

  • 8. POST MORTEM ACTIVATION OF HUMAN BLOOD FIBRINOLYTIC ENZYME IN SUDDEN AND NATURAL DEATHS.
    HABA K; KUMANO O; MOHRI M; TAKEMARU H; KAWANISHI K; TOBE S; KAMADA T; UENO S
    Acta Med Okayama (1952); 1963; 17():279-88. PubMed ID: 14168972
    [No Abstract]   [Full Text] [Related]  

  • 9. QUANTITATIVE EVALUATION OF FIBRINOLYTIC ENZYMES IN A SIMULATED HUMAN SYSTEM.
    MUNSON AE; BACK N; AMBRUS CM; LASSMAN H; LIPPSCHUTZ E; AMBRUS JL
    J Appl Physiol; 1964 May; 19():536-9. PubMed ID: 14174592
    [No Abstract]   [Full Text] [Related]  

  • 10. ACTIVATION OF THE FIBRINOLYTIC SYSTEM IN HUMAN BLOOD BY STREPTOKINASE AND CHANGES IN THIS SYSTEM AND IN THE EUGLOBULIN CLOT LYSIS TIME IN RELATION TO AGE AND SEX.
    KONTTINEN YP
    Scand J Clin Lab Invest; 1965; 17():SUPPL 82:1-111. PubMed ID: 14320094
    [No Abstract]   [Full Text] [Related]  

  • 11. [FIBRINOLYTIC ACTION OF CERTAIN SULFONATED POLYSACCHARIDES].
    AZNAR J; LASSO M
    Rev Clin Esp; 1963 Dec; 91():283-7. PubMed ID: 14119805
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON THE MECHANISM OF ACTION OF FIBRINOLYTIC SUBSTANCES].
    ROSOLLECK H
    Thromb Diath Haemorrh; 1963 Jul; 143():459-71. PubMed ID: 14081267
    [No Abstract]   [Full Text] [Related]  

  • 13. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 14. [CHANGES IN FIBRINOLYSIS AND BLOOD COAGULATION IN THROMBOLYTIC TREATMENT WITH STREPTOKINASE].
    DONNER L; KRCILEK A
    Cas Lek Cesk; 1965 Jun; 104():641-5. PubMed ID: 14321919
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE TREATMENT OF THROMBOSES BY LOCAL INFUSION OF FIBRINOLYTIC ENZYMES].
    BENZER H; BLUEMEL G; GOTTLOB R; PIZA F
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963 Nov; 304():775-80. PubMed ID: 14120202
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE STATUS OF THE BLOOD FIBRINOLYTIC ACTIVITY IN HEMOPHILIA PATIENTS].
    EFENDIEV FA; AKHUNDOVA AM; ABDULLAEV MM; EFENDIEV ZI
    Klin Med (Mosk); 1963 Jan; 41():122-5. PubMed ID: 14121310
    [No Abstract]   [Full Text] [Related]  

  • 17. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
    CLIFFTON EE
    Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024
    [No Abstract]   [Full Text] [Related]  

  • 18. [FIBRINOLYTIC PROPERTIES OF THE CONTACT FACTOR].
    AZNAR J
    Rev Esp Fisiol; 1964 Jun; 20():43-51. PubMed ID: 14185256
    [No Abstract]   [Full Text] [Related]  

  • 19. THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY.
    BLIX S
    Acta Med Scand; 1964 Nov; 176():649-50. PubMed ID: 14223542
    [No Abstract]   [Full Text] [Related]  

  • 20. [PRESENT STATUS OF THROMBOLYTIC THERAPY].
    VAIREL EG; ANTOINE G
    Sangre (Barc); 1964; 41():441-6. PubMed ID: 14248832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.